Marked the three players who are doing research actively in three different therapy areas. 
$BLUEBIRD BIO INC(BLUE)$ $SPARK THERAPEUTICS INC(ONCE)$ $uniQure(QURE)$ 

Looking forward to seeing some exciting clinical trial results from these companies. 

Personally, I would suggest an investor to take a "basket" approach in gene therapy unless you really have some good insights in one of the players. Of course, your money, your decision. Good luck! 


(source: Adam Koppel)

@美式咖啡加点奶 可以私聊哦